BioStock: Respiratorius sees great potential for new COPD treatment

Chronic obstructive pulmonary disease is today one of the most common causes of death globally. Although the market for treatments for the disease is vast, it is largely based on medicines with old modes of action. This is something that Lund-based Respiratorius wants to change with its RESP9000 project, which aims to develop an effective tool in the fight against the disease. The company sees several value-creating milestones on its way to clinical testing.

Read the full article at biostock.se:

https://www.biostock.se/en/respiratorius-sees-great-potential-for-new-copd-treatment/

This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se